Delilah Alvarado
Reporter | LinkedInDelilah is a reporter for BioPharma Dive. Before Industry Dive she covered business tech and startup news and has reported on social issues, politics and culture. She has a B.S. from Texas State University and is obsessed with dogs and horror films. She can also be reached on Signal at @DelilahAlvarado.70.
536 articles by Delilah Alvarado
-
J&J multiple myeloma drug gains edge in earlier stage disease
June 15, 2026 -
Ethyreal starts up with $101M and takes aim at a pair of immune diseases
June 10, 2026 -
Merck, Gilead report mixed outcomes in key lung cancer, HIV studies
June 9, 2026 -
An ADC specialist sinks on safety concerns for blood cancer drug
June 4, 2026 -
Celcuity breast cancer drug misses ‘lofty’ expectations in ASCO-spotlighted trial
June 2, 2026 -
ASCO ‘26: Bispecifics vs. ADCs, a ‘RAS’ revolution and a step change in prostate cancer
June 2, 2026 -
At ASCO, Merck makes case for a ‘cornerstone’ cancer drug
May 29, 2026 -
FDA delays decision on AstraZeneca breast cancer pill
May 27, 2026 -
Lilly dives into vaccine research with 3 biotech buyouts
May 26, 2026 -
Lilly snaps up Engage to advance non-viral genetic medicines
May 20, 2026 -
BioMarin drug acquired in buyout misses goal in rare disease study
May 19, 2026 -
Create Medicines raises $122M to bolster in vivo CAR-T therapies
May 14, 2026 -
Arvinas, Pfizer find new partner for ‘Protac’ breast cancer drug
May 12, 2026 -
GSK cuts deal with Sino to broaden reach of hepatitis B drug
May 11, 2026 -
Sarepta tumbles as its gene therapy sales decline further
May 7, 2026 -
Bayer to buy Perfuse for up to $2.45B, bolstering eye drug pipeline
May 6, 2026 -
Viridian data lift prospects for thyroid eye disease drug
May 5, 2026 -
Celcuity strengthens case for ASCO-spotlighted breast cancer drug
May 4, 2026 -
Moderna sees revenue bump from international COVID vaccine sales
May 1, 2026 -
UniQure, in ‘symbolic’ win, to seek UK approval of Huntington’s gene therapy
April 30, 2026 -
Coultreon banks $125M to support testing of former Galapagos immune drug
April 28, 2026 -
Oruka surges as long-acting psoriasis drug shows early promise
April 27, 2026 -
Sanofi MS drug rejected in US gets an endorsement in Europe
April 24, 2026 -
Erica Schwartz, ex-deputy surgeon general, picked to be next CDC director
April 16, 2026 -
Beeline, a Bain-backed biotech, debuts with immune drugs from Bristol Myers
April 15, 2026
